These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9389941)

  • 61. [Visceral leishmaniasis in immunocompetent adult with severe sepsis].
    Ezzouine H; Charra B; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2010 Mar; 29(3):255-6. PubMed ID: 20227234
    [No Abstract]   [Full Text] [Related]  

  • 62. [Visceral leishmaniasis and human immunodeficiency virus (HIV) infection in the south of France].
    Rosenthal E; Marty P; Cassuto JP
    Presse Med; 1995 Nov; 24(35):1666. PubMed ID: 8545394
    [No Abstract]   [Full Text] [Related]  

  • 63. [Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
    Ribelles N; Casals A; Vallés J; Clotet B
    Med Clin (Barc); 1989 May; 92(17):679. PubMed ID: 2747338
    [No Abstract]   [Full Text] [Related]  

  • 64. Monoclonal gammopathy associated with visceral leishmaniasis.
    Sharma V; Agarwal MP; Giri S
    Braz J Infect Dis; 2010; 14(3):297-8. PubMed ID: 20835517
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lingual leishmaniasis complicating visceral disease.
    Mazumder SA; Pandey S; Brewer SC; Baselski VS; Weina PJ; Land MA; Fleckenstein JM
    J Travel Med; 2010; 17(3):212-4. PubMed ID: 20536896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HIV infection, visceral leishmaniasis and Guillain-Barré syndrome in the same patient: a case report.
    Kumar N; Pandey K; Das VN; Sinha PK; Topno RK; Lal CS; Bimal S; Verma N; Das P
    Ann Trop Med Parasitol; 2008 Mar; 102(2):185-8. PubMed ID: 18318942
    [No Abstract]   [Full Text] [Related]  

  • 68. Visceral leishmaniasis: an unusual cause of isolated lymphadenopathy.
    Palmic P; Blanche P; Bouscary D; Birsen R
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732374
    [No Abstract]   [Full Text] [Related]  

  • 69. Severe Visceral Leishmaniasis Associated With COVID-19 and Complicated by Hemophagocytic Syndrome.
    Pessoa FS; Salgado IADSC; Gonçalves VC; Martins ACRR; Pessoa LS; Braga Junior L
    Pediatr Infect Dis J; 2022 Dec; 41(12):e544-e545. PubMed ID: 36102700
    [No Abstract]   [Full Text] [Related]  

  • 70. Esophageal leishmaniasis in a patient infected with the human immunodeficiency virus.
    Gutiérrez-Macías A; Alonso-Alonso JJ; Aguirre-Errasti C
    Clin Infect Dis; 1995 Jul; 21(1):229-30. PubMed ID: 7578744
    [No Abstract]   [Full Text] [Related]  

  • 71. Contribution of serological tests to the diagnosis of visceral leishmaniasis in patients infected with the human immunodeficiency virus.
    Gari-Toussaint M; Leliévre A; Marty P; Le Fichoux Y
    Trans R Soc Trop Med Hyg; 1994; 88(3):301-2. PubMed ID: 7974668
    [No Abstract]   [Full Text] [Related]  

  • 72. Multiple dermatofibroma-like lesions in a human immunodeficiency virus-positive patient coinfected with visceral leishmaniasis.
    Forsyth SF; Lawn SD; Miller RF; Fernando JJ; Lockwood DN; Vega-Lopez F
    Br J Dermatol; 2003 Jan; 148(1):185-7. PubMed ID: 12534629
    [No Abstract]   [Full Text] [Related]  

  • 73. Don't forget Leishmania!
    Sendino A; Javier Barbado F; Vázquez-Rodríguez JJ
    Clin Infect Dis; 1993 Nov; 17(5):944-5. PubMed ID: 8286657
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical and experimental advances in treatment of visceral leishmaniasis.
    Murray HW
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2185-97. PubMed ID: 11451673
    [No Abstract]   [Full Text] [Related]  

  • 75. Guidelines for visceral leishmaniasis and HIV co-infection.
    Burki T
    Lancet Infect Dis; 2022 Aug; 22(8):1124-1125. PubMed ID: 35870462
    [No Abstract]   [Full Text] [Related]  

  • 76. Demographic characteristics and prevalence of asymptomatic
    Yimer M; Takele Y; Yizengaw E; Nibret E; Sumova P; Volf P; Yismaw G; Alehegn M; Rowan A; Müller I; Cotton JA; Chapman LAC; Kropf P
    Front Epidemiol; 2024; 4():1367387. PubMed ID: 38655403
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Amphotericin B lipid complex: in visceral leishmaniasis.
    Goldsmith DR; Perry CM
    Drugs; 2004; 64(17):1905-11; discussion 1912-3. PubMed ID: 15329037
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cutaneous leishmaniasis].
    Enk CD; Gardlo K; Hochberg M; Ingber A; Ruzicka T
    Hautarzt; 2003 Jun; 54(6):506-12. PubMed ID: 12759734
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Practical guide for the treatment of leishmaniasis.
    Davidson RN
    Drugs; 1998 Dec; 56(6):1009-18. PubMed ID: 9878989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. AIDS and leishmaniasis.
    Davidson RN
    Genitourin Med; 1997 Aug; 73(4):237-9. PubMed ID: 9389941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.